Company intelligence / Profile preview

Purdue Pharma

Stamford, Connecticut, United Statespurduepharma.com ↗

Ownership: Private
Employees: ~1700
Development stage: Commercial

Overview

Purdue Pharma was a major pharmaceutical company known for developing and marketing OxyContin, a time-release opioid pain medication. The company faced numerous lawsuits for its role in the opioid epidemic, with allegations of misleading marketing practices regarding the addiction risks of OxyContin. In 2007, an affiliate pleaded guilty to federal charges of misbranding OxyContin as less addictive than it actually was. The company filed for bankruptcy in 2019 amid ongoing litigation.

Therapeutic areas: Neurology
Modalities: Small moleculesopioid medications
Industry: Pharma

Drug pipeline

10 assets

oxycodone

Approved

9 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Purdue Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Purdue Pharma.

Explore the full profile